Long-Term Outcomes of Repeat Hepatic Resection in Patients with Recurrent Hepatocellular Carcinoma and Analysis of Recurrent Types and Their Prognosis: A Single-Center Experience in China

被引:187
作者
Huang, Zhi-yong [1 ,2 ]
Liang, Bin-yong [1 ,2 ]
Xiong, Min [3 ]
Zhan, Da-qian [1 ,2 ]
Wei, Shuang [1 ,2 ]
Wang, Guo-ping [4 ]
Chen, Yi-fa [1 ,2 ]
Chen, Xiao-ping [1 ,2 ]
机构
[1] Huazhong Univ Sci & Technol, Res Lab, Wuhan 430074, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Hepat Surg Ctr,Dept Surg, Wuhan 430074, Peoples R China
[3] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Gynecol, Wuhan 430074, Peoples R China
[4] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Pathol, Wuhan 430074, Peoples R China
基金
中国国家自然科学基金;
关键词
INTRAHEPATIC METASTASIS; MULTICENTRIC OCCURRENCE; CLONAL ORIGIN; HEPATECTOMY; MULTIPLE; SURVIVAL; 2ND; PATTERNS; TUMOR;
D O I
10.1245/s10434-012-2269-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Recurrent hepatocellular carcinoma (HCC) after curative resection usually originates from intrahepatic metastasis (IM) or multicentric occurrence (MO). The long-term outcomes of repeat hepatic resection in patients with different types of recurrence have not been evaluated in a large number of patients. The surgical indications for recurrent HCC remain controversial. The purpose of this study was to investigate long-term outcomes of repeat hepatic resection and clinicopathologic factors associated with different types of recurrent HCC, and to single out principle differentiating factors between IM and MO. 82 patients who underwent repeat hepatic resection for recurrent HCC were retrospectively studied. The recurrent type was evaluated by histopathologic analysis of primary and recurrent HCC. The recurrence and survival rates as well as clinicopathologic factors associated with different types of recurrence were analyzed. 45 patients (54.9%) had confirmed with IM, and 37 patients (45.1%) had with MO. The recurrence rates in the MO patients after initial or repeat resection were significantly lower than those in the IM patients (p < 0.001). The overall survival rates in the MO patients after initial or repeat resection were significantly higher than those in the IM patients (p < 0.001). Recurrence-free time was identified as the most significant differentiating factor between IM and MO. A recurrence-free time of 18 months after initial resection was a significant cutoff time point for differentiating between IM and MO. A recurrence-free time of less than or equal to 18 months and microvascular invasion at repeat resection were independent adverse prognostic factors for overall survival after repeat hepatic resection. Repeat hepatic resection resulted in much higher survival rates in the MO patients than in the IM patients. Repeat hepatic resection could be recommended for those patients in whom the recurrent HCC occurs more than 18 months after initial resection.
引用
收藏
页码:2515 / 2525
页数:11
相关论文
共 37 条
[1]
Aaltonen LA., 2000, PATHOLOGY GENETICS T, P159
[2]
Arii S, 1998, J Hepatobiliary Pancreat Surg, V5, P86, DOI 10.1007/PL00009956
[3]
CLONAL ORIGIN OF RECURRENT HEPATOCELLULAR CARCINOMAS [J].
CHEN, PJ ;
CHEN, DS ;
LAI, MY ;
CHANG, MH ;
HUANG, GT ;
YANG, PM ;
SHEU, JC ;
LEE, SC ;
HSU, HC ;
SUNG, JL .
GASTROENTEROLOGY, 1989, 96 (02) :527-529
[4]
Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma [J].
Chen, YJ ;
Yeh, SH ;
Chen, JT ;
Wu, CC ;
Hsu, MT ;
Tsai, SF ;
Chen, PJ ;
Lin, CH .
GASTROENTEROLOGY, 2000, 119 (02) :431-440
[5]
Liver Resection for Transplantable Hepatocellular Carcinoma Long-Term Survival and Role of Secondary Liver Transplantation [J].
Cherqui, Daniel ;
Laurent, Alexis ;
Mocellin, Nicolas ;
Tayar, Claude ;
Luciani, Alain ;
Jeanne Tran Van Nhieu ;
Decaens, Thomas ;
Hurtova, Monika ;
Memeo, Riccardo ;
Mallat, Ariane ;
Duvoux, Christophe .
ANNALS OF SURGERY, 2009, 250 (05) :738-746
[6]
Cheung ST, 2002, CANCER RES, V62, P4711
[7]
Prognostic factors and optimal treatment strategy for intrahepatic nodular recurrence after curative resection of hepatocellular carcinoma [J].
Choi, Gi-Hong ;
Kim, Dong-Hyun ;
Kang, Chang-Moo ;
Kim, Kyung-Sik ;
Choi, Jin-Sub ;
Lee, Woo-Jung ;
Kim, Byong-Ro .
ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (02) :618-629
[8]
Comparison of Recurrence of Hepatocellular Carcinoma After Resection in Patients with Cirrhosis to Its Occurrence in a Surveilled Cirrhotic Population [J].
Cucchetti, Alessandro ;
Piscaglia, Fabio ;
Caturelli, Eugenio ;
Benvegnu, Luisa ;
Vivarelli, Marco ;
Ercolani, Giorgio ;
Cescon, Matteo ;
Ravaioli, Matteo ;
Grazi, Gian Luca ;
Bolondi, Luigi ;
Pinna, Antonio Daniele .
ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (02) :413-422
[9]
Use of Surveillance for Hepatocellular Carcinoma Among Patients With Cirrhosis in the United States [J].
Davila, Jessica A. ;
Morgan, Robert O. ;
Richardson, Peter A. ;
Du, Xianglin L. ;
McGlynn, Katherine A. ;
El-Serag, Hashem B. .
HEPATOLOGY, 2010, 52 (01) :132-141
[10]
EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO